ASH 2025 - Aggressive B-Zell-Lymphome: Neue Optionen für ältere Patient:innen, Zelltherapien und Monitoring

From Hämatologie Shortcasts by Dr. med. Richard Schabath, Dr. med. Andreas Hausmann, Dr. med. Stephan Fuhrmann

February 5, 2026 · 18 min · Season 5 · Episode 1

About this episode

The episode discusses new treatment options for aggressive B-cell lymphomas presented at ASH 2025, focusing on therapies for older patients and the role of cell therapies.

People in this episode

Host: Dr. Stephan Fuhrmann

Guest: Prof. Malte von Bonin

Topics covered

B-Zell-Lymphome
Zelltherapien
Chemotherapie
Patientenmanagement
Klinische Studien
Monitoring

Keywords

B-Zell-Lymphome
Chemotherapie
Zelltherapie
Patientenmanagement
Klinische Daten
MRD-Konzept

Mentioned in this episode

Organizations: ASH

Products: Epcoritamab, R-mini-CHOP, Rituximab, Polatuzumab, Glofitamab, CAR-T-Zell-Therapie, Axi-Cel, Liso-Cel, bispezifischen Antikörpern, ctDNA

More episodes of Hämatologie Shortcasts

AML – Revolution oder Evolution? · February 27, 2026 · 26 min
ASH 2025 – T-Zell-Lymphome: Neue Targets, frühe Rezidive und klinische Konsequenzen · January 19, 2026 · 29 min
ASH 2025 – Epcoritamab & Co.: Wie sich die Therapie des follikulären Lymphoms verändert · December 19, 2025 · 20 min
ASH 2025 - AML im Umbruch? · December 17, 2025 · 33 min
ASH 2025 – Neuigkeiten zur CLL · December 16, 2025 · 24 min
ASH 2025 – Latebreaker · December 4, 2025 · 34 min

Explore listener stats, chart rankings, contacts and more on the Hämatologie Shortcasts podcast page.